Usefulness of the Reborn Soup for the Reduction of Salt Intake.


Journal

Journal of nutrition and metabolism
ISSN: 2090-0724
Titre abrégé: J Nutr Metab
Pays: United States
ID NLM: 101526296

Informations de publication

Date de publication:
2024
Historique:
received: 23 01 2024
revised: 04 07 2024
accepted: 18 07 2024
medline: 5 9 2024
pubmed: 5 9 2024
entrez: 5 9 2024
Statut: epublish

Résumé

The purpose of the present study was to investigate the influence of reborn soup on the perceptions of saltiness and palatability. Subjects comprised 103 staff working at Kokura Daiichi Hospital (22 males, 81 females, and mean age: 35 ± 12 years old). They tested soups (commercially available soup with 0.9% NaCl solutions (A), commercially available soup with 0.6% NaCl solutions (B), and reborn soup diluted to 0.6% NaCl solutions (C)). Evaluations of saltiness and palatability for each solution were conducted using a visual analog scale in a double-blinded randomized manner. We estimated 24-hour salt excretion using spot urine samples to estimate salt intake and also assessed blood pressure, the awareness of salt intake using a self-description questionnaire score, and other confounding factors including lifestyle factors. In all subjects, the average estimated salt intake was 9.0 ± 2.0 g/day, and the rates at which subjects met the established salt intake targets were 15.1% in 73 females without hypertension (<6.5 g/day), 23.5% in 17 males without hypertension (<7.5 g/day), and 0.0% in 13 subjects with hypertension (<6.0 g/day). In both saltiness and palatability, B scored significantly lower than A, but C scored significantly higher than B. Salt intake levels were categorized into tertiles (Q1, lowest; Q3, highest). C scored significantly higher for palatability in the Q1 group than in the Q3 group. Most participants exceeded the established targets of salt intake. The high-salt-intake group might be able to feel less palatable. Our results indicate that reborn soup may be effective in reducing salt intake without loss of palatability.

Identifiants

pubmed: 39234056
doi: 10.1155/2024/6090466
pmc: PMC11374420
doi:

Types de publication

Journal Article

Langues

eng

Pagination

6090466

Informations de copyright

Copyright © 2024 Yuko Ohta et al.

Déclaration de conflit d'intérêts

The authors declare that they have no conflicts of interest.

Auteurs

Yuko Ohta (Y)

Division of General Internal Medicine Kyushu Dental University, Fukuoka, Japan.

Satoko Sakata (S)

Department of Medicine and Clinical Science Graduate School of Medical Sciences Kyushu University, Fukuoka, Japan.

Kazuhiro Ohta (K)

Internal Medicine and Gastroenterology Ohta Clinic, Fukuoka, Japan.

Masahiko Kusano (M)

Reborn TK Japan Co. Ltd, Fukuoka, Japan.

Ritsuko Fujisawa (R)

Division of General Internal Medicine Kyushu Dental University, Fukuoka, Japan.

Yuji Komorita (Y)

Division of General Internal Medicine Kyushu Dental University, Fukuoka, Japan.

Yukie Kuwahara (Y)

Kokura Daiichi Hospital, Fukuoka, Japan.

Yuki Fukamatsu (Y)

Kokura Daiichi Hospital, Fukuoka, Japan.

Hiroshi Tsuruta (H)

Kokura Daiichi Hospital, Fukuoka, Japan.

Hidetoshi Nakamura (H)

Kokura Daiichi Hospital, Fukuoka, Japan.

Takuya Tsuchihashi (T)

Steel Memorial Yawata Hospital, Fukuoka, Japan.

Classifications MeSH